Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
311.15
+1.26 (0.41%)
Jul 27, 2026, 4:00 PM EDT - Market closed
Cencora Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 328,680 | 321,333 | 293,959 | 262,173 | 238,587 | 213,989 |
Revenue Growth | 5.95% | 9.31% | 12.12% | 9.89% | 11.49% | 12.69% |
Gross Profit Gross Profit Growth | 12,521 | 11,479 | 9,910 | 8,959 | 8,296 | 6,943 |
Operating Income Operating Income Growth | 2,789 | 2,629 | 2,175 | 2,341 | 2,366 | 2,354 |
Net Income Net Income Growth | 2,549 | 1,554 | 1,509 | 1,745 | 1,699 | 1,540 |
Earnings Per Share EPS Growth | 13.05 | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 |
EPS Growth | 51.39% | 5.71% | -11.72% | 6.09% | 8.80% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
US Human Health US Human Health Growth | - | 285,288 | 259,974 | 229,717 | 207,284 | 197,777 |
US Animal Health US Animal Health Growth | - | 5,695 | 5,366 | 5,043 | 4,816 | 4,684 |
International Alliance Healthcare International Alliance Healthcare Growth | 25,671 | 24,395 | 23,062 | 22,349 | 21,890 | 7,373 |
Other Healthcare Solutions Other Healthcare Solutions Growth | 5,254 | 5,971 | 5,566 | 5,069 | 4,601 | 4,156 |
Eliminations Eliminations Growth | -71.62 | -15.53 | -8.37 | -4.49 | -4.87 | -2.33 |
Revenue (Total) Revenue (Total) Growth | 328,680 | 321,333 | 293,959 | 262,173 | 238,587 | 213,989 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 2,176 | 4,356 | 3,133 | 2,592 | 3,388 | 2,547 |
Total Debt Total Debt Growth | 12,386 | 7,681 | 4,388 | 4,787 | 5,703 | 6,684 |
Net Cash (Debt) Net Cash Growth | -10,209 | -3,325 | -1,255 | -2,195 | -2,315 | -4,137 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -52.27 | -17.03 | -6.27 | -10.73 | -10.96 | -19.84 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,276 | 3,875 | 3,485 | 3,911 | 2,703 | 2,667 |
Capital Expenditures CapEx Growth | -718.02 | -667.98 | -487.17 | -458.36 | -496.32 | -438.22 |
Free Cash Flow Free Cash Flow Growth | 1,558 | 3,207 | 2,998 | 3,453 | 2,207 | 2,228 |
Free Cash Flow Growth | -56.42% | 6.99% | -13.19% | 56.47% | -0.97% | 21.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 3.81% | 3.57% | 3.37% | 3.42% | 3.48% | 3.24% |
Operating Margin | 0.85% | 0.82% | 0.74% | 0.89% | 0.99% | 1.10% |
Pretax Margin | 1.07% | 0.70% | 0.68% | 0.82% | 0.91% | 1.04% |
Profit Margin | 0.78% | 0.49% | 0.52% | 0.66% | 0.70% | 0.72% |
FCF Margin | 0.47% | 1.00% | 1.02% | 1.32% | 0.92% | 1.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.400 | 2.200 | 2.040 | 1.940 | 1.840 | 1.760 |
Dividend Per Share Growth | 8.80% | 7.84% | 5.16% | 5.44% | 4.54% | 6.02% |
Dividend Yield | 0.77% | 0.72% | 0.93% | 1.09% | 1.39% | 1.49% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 23.84 | 39.26 | 29.89 | 21.10 | 16.83 | 16.16 |
Forward PE | 16.71 | 18.36 | 15.53 | 14.46 | 12.01 | 11.51 |
P/FCF Ratio | 38.85 | 18.90 | 14.64 | 10.47 | 12.65 | 11.15 |
PS Ratio | 0.18 | 0.19 | 0.15 | 0.14 | 0.12 | 0.12 |